{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Does Payer Coverage Drive Genomic Test Utilization in the United States?",
    "url": "https://www.lexblog.com/2020/08/26/does-payer-coverage-drive-genomic-test-utilization-in-the-united-states/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-X3QJFQ11",
        "url": "https://www.lexblog.com/lib/X3QJFQ11/"
    },
    "datePublished": "2020-08-26T22:00:06-04:00",
    "dateModified": "2020-08-26T22:00:07-04:00",
    "author": {
        "@type": "Person",
        "name": "Antoinette F. Konski"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Foley & Lardner LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Personalized Medicine Bulletin",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.foley.com/en/insights/publications/2020/08/does-payer-coverage-drive-genomic-test-utilization",
    "sourceStability": "may-move"
}